Drug firms may play bigger role than thought in medical lit
(NEWSER) - Ghostwriters funded by a drug firm were deeply involved in writing papers supporting therapies that helped the firm’s sales boom, court papers show. The 26 scientific papers, published in medical journals from 1998 to 2005, highlighted the benefits of hormone replacement therapy over the risks, a boon to Wyeth, which paid the writers. The news hints at the extent to which drug firms may pull strings in medical literature, the New York Times reports. More»
